These results suggest that m/lEVs have a direct regulatory effect over B cells through the BCR activation that seems to be not efficient for T cell-dependent stimuli, and in patients with RA because of the impact of these vesicles over cells of the innate immune system. The gene discussed is BCR; the disease is rheumatoid arthritis.